Frederick S Buckner MD
Associate Professor, Medicine, University of Washington School of Medicine
Join to View Full Profile
PO Box# 1959Seattle, WA 98195
Phone+1 206-598-7600
Fax+1 206-598-6963
Are you Dr. Buckner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Frederick Buckner, MD is an infectious disease specialist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Minnesota. He is affiliated with UW Medicine/University of Washington Medical Center, UW Medicine/Harborview Medical Center, and Seattle VA Medical Center.
Education & Training
University of Washington School of MedicineClass of 1988
Certifications & Licensure
WA State Medical License 1992 - 2027
MN State Medical License 1991 - 1993
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- A novel methionyl-tRNA synthetase inhibitor targeting gram-positive bacterial pathogens.Nora M R Molasky, Zhongsheng Zhang, J Robert Gillespie, John Domagala, Dawn Reyna
Antimicrobial Agents and Chemotherapy. 2024-12-05 - Descriptive and molecular epidemiology of leishmaniasis diagnosed from clinical samples in the United States, 2021-2022.Thao T Truong, Karissa Crawford, Ichih Wang-McGuire, Kendal Jensen, Aisha Mushtaq
Microbiology Spectrum. 2024-10-03 - 12 citationsSpontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection.Muhammad M. Hasan, Erin E. Stebbins, Robert K. M. Choy, J. Robert Gillespie, Eugenio L. de Hostos
Antimicrobial Agents and Chemotherapy. 2021-05-18
Press Mentions
IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA DesignationNovember 16th, 2021
Grant Support
- Drug Discovery for Chagas DiseaseUNIVERSITY OF WASHINGTON2019–2026
- Developing methionyl tRNA synthetase inhibitors as therapeutics for Chagas diseaseUNIVERSITY OF WASHINGTON2020–2025
- Structure-Based Optimization Of T. Brucei Methionyl Trna Synthetase InhibitorsNational Institute Of Allergy And Infectious Diseases2012
- Rational Development Of Anti-Trypanosoma Cruzi DrugsNational Institute Of Allergy And Infectious Diseases2006–2012
- Biochemistry Of Protein PrenylationNational Institute Of Allergy And Infectious Diseases2008–2011
- Target Selection And Ligand DiscoveryNational Institute Of Allergy And Infectious Diseases2006–2008
- Sterol Biosynthesis In Trypanosomatid ParasitesNational Institute Of Allergy And Infectious Diseases2001–2004
- Immune Modulation Of Trypanosoma Cruzi InfectionNational Institute Of Allergy And Infectious Diseases1994–1998
